Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P174. Prediction of response to anti-TNF treatment in Crohn's disease using magnetic resonance enterography (MRE) findings
Authors:

D. Gibson1, A. Smyth1, D. Keegan1, K. Byrne1, E. Ryan1, D. Murphy2, G. Cullen1, H. Mulcahy1, D. Malone2, G. Doherty1, 1St Vincent's Hospital, Centre for Colorectal Disease, Dublin, Ireland, 2St Vincent's Hospital, Radiology, Dublin, Ireland

P174. Ulcerative colitis experience and management across countries: An international survey of patients and physicians
P174

Diagnostic value of a novel combination score of disease activity in a real-life IBD cohort.

Authors:

A. Bodelier*1, 2, D. Jonkers2, T. Van den Heuvel2, E. de Boer2, W. Hameeteman2, A. Masclee2, M. Pierik2

1Amphia Ziekenhuis, Internal Medicine & Gastroenterology, Breda, Netherlands, 2Maastricht University Medical Center+, Internal Medicine - Division Gastroenterology-Hepatology, Maastricht, Netherlands

P175.

Patients' perceptions, attitudes, and experiences about the management of mild-to-moderate ulcerative colitis

Authors:

F. Casellas1, D. Ginard2, S. Riestra3, N. Alfaro4, 1Hospital Universitari Vall d'Hebron, Unitat Atenció Crohn-Colitis, Barcelona, Spain, 2Hospital Universitario Son Espases, Gastroenterology Department, Palma de Mallorca, Spain, 3Hospital Universitario Central de Asturias, Gastroenterology Department, Oviedo, Spain, 4Advanced Techniques in Health Services Research (TAISS), Research, Madrid, Spain

P175. Increased fracture risk assessed by Fracture Risk Assessment Tool (FRAX) in Greek patients with Crohn's disease
P175. Post-operative complications in pediatric inflammatory bowel disease: a population-based study
Authors:

E. Penninck1, J. Salleron2, M. Fumery3, G. Savoye4, D. Turck5, J.-L. Dupas6, F. Vasseur7, E. Lerebours4, L. Peyrin-Biroulet8, J.-F. Colombel1, C. Gower-Rousseau7, 1University Hospital, Gastroenterology, Lille, France, 2University Hospital EA 2694, Biostatistics, Lille, France, 3Amiens University and Hospital, Gastroenterology, Amiens, France, 4University Hospital, Gastroenterology, Rouen, France, 5University Hospital, Pediatric Unit, Lille, France, 6University Hospital, Gastroenterology, Amiens, France, 7University Hospital, Epidemiology EA 2694, Lille, France, 8University Hospital, Gastroenterology, Nancy, France

P175. Thiopurine metabolism in inflammatory bowel diseases: A worldwide survey of experts
P175

Clinical outcome of ulcerative colitis with mucosal healing demonstrated by white light endoscopy but with subtle abnormalities detected by high definition iSCAN endoscopy

Authors:

M. Fort Gasia*1, R. Panaccione1, G. Kaplan1, S. Ghosh1, X. Gui2, M. Iacucci1

1University of Calgary, Department of Gastroenterology, Inflammatory Bowel Disease Clinic, Alberta, Canada, 2University of Calgary, Department of Pathology, Calgary, Canada

P176.

Patient reported outcome measures derived from the Crohn's Disease Activity Index: Correlation between PRO2 and PRO3 scores and CDAI-defined clinical thresholds

Authors:

R. Khanna1, G. D'Haens1,2, B.G. Feagan1,3, W.J. Sandborn1,4, M.K. Vandervoort1, G. Zou1, R.L. Rolleri5, E. Bortey5, B.G. Levesque1,4, 1Robarts Clinical Trials Inc., Robarts Research Institute, Western University, London, Ontario, Canada, 2University of Amsterdam, Academic Medical Center, Amsterdam, Netherlands, 3Western University, Department of Epidemiology and Biostatistics, Department of Medicine, London Ontario, Canada, 4University of California, San Diego, Division of Gastroenterology, La Jolla, United States, 5Salix Pharmaceuticals Inc., Clinical Development, Raleigh North Carolina, United States

P176. Endoscopic treatment with self-expanding metal stents in Crohn's disease strictures
P176. Impact of capsule endoscopy on management of Crohn's disease: A single center experience
P176. PillCam colon (C2) vs colonoscopy in the assessment of colon mucosa in patients with ulcerative colitis
Authors:

M. San Juan Acosta1, A. Belda Cuesta1, Á. Caunedo1, F. Argüelles Arias1, L. Castro Laria1, B. Gómez Rodríguez1, M.L. Morales Barroso1, J. Romero Vázquez1, J.M. Herrerías Gutiérrez1, 1University Hospital Virgen Macarena, Gastroenterology and Hepatology, Seville, Spain

P176

Irritable bowel syndrome frequency in Inflammatory Bowel Disease during both clinical and deep remission and its association with fecal calprotectin

Authors:

B. Boztepe*1, O. Sezgin2, E. Altintas3, D. Ovla4

1Kesan State Hospital, İnternal Medicine, Edirne , Turkey, 2Mersin , Gastroenterology, Mersin, Turkey, 3Mersin, Gastroenterology, Mersin, Turkey, 4Mersin, Biostatistics and Bioinformatics, Mersin, Turkey

P177.

Phenotypic and therapeutic differences in Crohn's disease depending on age at diagnosis

Authors:

E. Leo Carnerero, G. Ontanilla Clavijo, C. Trigo Salado, M.D. De La Cruz Ramirez, A. Araujo Miguez, J.M. Herrera Justiniano, J.L. Marquez Galan, HU Virgen del Rocío, UGC Digestive Diseases, Seville, Spain

P177. Adalimumab for patients with Crohn's disease and secondary loss of response or severe allergy to infliximab
P177. Ileocolonoscopy and small intestine contrast ultrasonography (SICUS) as predictors of clinical outcome after ileo-colonic resection for Crohn's disease: A prospective study at 5 years
P177. Phenotype of inflammatory bowel disease at diagnosis in the Netherlands: a population-based inception cohort study (the DELTA cohort)
Authors:

V. Nuij1, Z. Zelinkova1, M. Rijk2, R. Beukers3, R. Ouwendijk4, R. Quispel5, A. van Tilburg6, T. Tang7, H. Smalbraak8, K. Bruin9, F. Lindenburg10, L. Peyrin-Biroulet11, C.J. van der Woude1, 1Erasmus Medical Center, Department of Gastroenterology & Hepatology, Rotterdam, Netherlands, 2Amphia Hospital, Gastroenterology & Hepatology, Breda, Netherlands, 3Albert Schweitzer Hospital, Gastroenterology & Hepatology, Dordrecht, Netherlands, 4Ikazia Hospital, Gastroenterology & Hepatology, Rotterdam, Netherlands, 5Reinier de Graaf Hospital, Gastroenterology and Hepatology, Delft, Netherlands, 6Sint Franciscus Gasthuis, Gastroenterology & Hepatology, Rotterdam, Netherlands, 7IJsselland Hospital, Gastroenterology & Hepatology, Capelle aan den IJssel, Netherlands, 8Lievensberg Hospital, Internal Medicine, Bergen op Zoom, Netherlands, 9Tweesteden Hospital, Gastroenterology & Hepatology, Tilburg, Netherlands, 10Franciscus Hospital, Gastroenterology and Hepatology, Roosendaal, Netherlands, 11Nancy University Hospital, Université de Lorraine, Gastroenterology and Hepatology, Vandoeuvre-les-Nancy, France

P177

Patency capsule in patients with established Crohn's disease undergoing videocapsule endoscopy of the small bowel

Authors:

A. Nemeth1, U. Kopylov*2, A. Koulaouzidis3, G.W. Johansson4, R. Eliakim5, H. Thorlacius6, D. Amre7, R. Eliakim5, E.G. Seidman8, E. Toth4

1Skåne University Hospital, Lund University, Department of Gastroenterology, Malmo, Sweden, 2Sheba Medical Center, Gastroenterology, Tel Hashomer, Israel, 3Royal Infirmary of Edinburgh, Endoscopy Unit, Centre for Liver and Digestive Disorders, Edinburgh, United Kingdom, 4University Hospital Skane, Department of Hepatology and Gastroenterology, Malmö, Sweden, 5Chaim Sheba Medical Center, Gastroenterology, Ramat Gan, Israel, 6University Hospital Skane, Department of Surgery, Malmö, Sweden, 7Saint Justine Medical Center, Research Institute, Montreal, Canada, 8McGill University, Division of Gastroenterology, Montreal Quebec, Canada

P178.

Outcomes of pregnancies among women with inflammatory bowel disease: results from a single-center cohort

Authors:

A. Hernandez Camba1, D. Vasquez Carlon2, L. Ramos1, E. Padron2, M. Carrillo Palau1, N. Hernandez Alvarez-Buylla1, E. Quintero Carrion1, 1Hospital Universitario de Canarias, Gastroenterology, La Laguna, SantaCruz de Tenerife, Spain, 2Hospital Universitario de Canarias, Obstetrics and Gynecology, La Laguna, Santa Cruz de Tenerife, Spain

P178. An audit of adherence to anti-TNF therapy in patients with inflammatory bowel disease